About Our Team
Founded in 1990, Apollo Global Management, Inc. is a leading global alternative asset manager and a valueoriented investor in private equity, real estate and credit-oriented capital markets. As of September 30, 2022, Apollo has $523 billion total assets under management, and has offices in New York, Los Angeles, Houston, Bethesda, San Diego, London, Frankfurt, Madrid, Luxembourg, Mumbai, Delhi, Singapore, Hong Kong and Shanghai.
To date, Apollo and its affiliates manage more than $5 billion across the healthcare and life sciences industries.
GeneSuites offers the most advanced and cost-efficient cGMP multi-modal manufacturing solution for cell and gene therapy companies looking to accelerate speed to market, minimize operating risk while maximizing process control, capital efficiencies and scalability.
The GeneSuites team has a proven track record of developing, managing and negotiating multi-million square feet of life science and cGMP biomanufacturing space.
Supported by a Team of Best-in-Class Experts